Thompson Davis & Co’s Opko Health OPK Stock Holding History

Thompson Davis & Co’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-28,200	Closed	-$89K	–	725
2018 Q1	$89K	Buy	+28,200	New	+$114K	0.23%	104
2016 Q4	–	Sell	-250	Closed	-$3K	–	1183
2016 Q3	$3K	Hold	250	–	–	0.01%	942
2016 Q2	$2K	Hold	250	–	–	﹤0.01%	959
2016 Q1	$3K	Hold	250	–	–	﹤0.01%	894
2015 Q4	$3K	Buy	+250	New	+$2.51K	﹤0.01%	948
2015 Q3	–	Sell	-8,000	Closed	-$129K	–	1213
2015 Q2	$129K	Sell	8,000 -500	-6%	-$7.78K	0.15%	159
2015 Q1	$120K	Buy	8,500 +6,500	+325%	+$84.6K	0.14%	153
2014 Q4	$20K	Buy	2,000 +1,000	+100%	+$8.56K	0.02%	516
2014 Q3	$9K	Hold	1,000	–	–	0.01%	733
2014 Q2	$9K	Sell	1,000 -250	-20%	-$2.18K	0.01%	502
2014 Q1	$12K	Hold	1,250	–	–	0.02%	463
2013 Q4	$11K	Buy	+1,250	New	+$12.6K	0.02%	438

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Thompson Davis & Co's OPK Position: Q2 2018 in Review

Thompson Davis & Co sold out of Opko Health (OPK) in Q2 2018, closing a stake of 28,200 shares — an estimated $89K sold.

Thompson Davis & Co first reported a position in OPK in Q4 2013 and held it in 12 quarters. The position peaked at $129K in Q2 2015. 214 funds tracked by Wall St. Rank hold OPK as of Q2 2018.

Thompson Davis & Co reported no remaining Opko Health position as of Q2 2018 after selling out during the quarter.
Thompson Davis & Co sold 28,200 Opko Health shares in Q2 2018, an estimated $89K.
Thompson Davis & Co first reported a position in Opko Health in Q4 2013 and held it in 12 quarters.
Thompson Davis & Co's Opko Health position peaked at $129K in Q2 2015.
214 funds tracked by Wall St. Rank held Opko Health as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.